Episode Details
Back to EpisodesFDA Approves Genentech's Susvimo Ocular Implant for DME
Published 1 year, 3 months ago
Description
The FDA approves a label expansion for Genentech’s Susvimo implant; Iantrek completes the first commercial cases of its C.Rex micro-interventional system; and there are several executive leadership announcements made in ophthalmology.
Learn more about your ad choices. Visit megaphone.fm/adchoices